Aside from the metabolic changes seen in AML-LSC regardless of AML mutational subtypes, more specific metabolic alterations are seen in AML subtypes that bear mutations in specific metabolic regulators, such as isocitrate dehydrogenases (IDH1/2) or TET2 (109). The gene discussed is TET2; the disease is acute myeloid leukemia.